click below
click below
Normal Size Small Size show me how
Fund/Pharm Practice
Chapter 3
| Question | Answer |
|---|---|
| U, IU, QD, QOD, TRAILING 0, LACK OF LEADING 0, MS, MSO4 AND MgSO4 | THE MINIMUM DO NOT USE LIST |
| THE NUMBER OF ABBREVIATIONS THAT MUST BE IDENTIFIED BY EACH ORGINAZATION TO ADD TO THE MINIMUM LIST | THREE |
| THEY CREATED THE DO NOT USE LIST | THE JOINT COMMISSION |
| WHO RECOMMENDS ADDING TO THE 'MINIMUM REQUIRED DO NOT USE' LIST | INSTITUTE FOR SAFE MEDICAL PRACTICES |
| CHEMICAL KNOWN OR BELIEVED TO HAVE THERAPEUTIC EFFECT | ACTIVE INGREDIENT |
| SUBSTANCE THAT OPPOSES THAT ACTION OF ANOTHER DRUG OR SUBSTANCE | ANTAGONIST |
| LIQUID DOSAGE FORM THAT CONTAINS FLAVORED WATER AND ALCOHOL MIXTURE | ELIXIR |
| ADDITIONAL INSTRUCTIONS FOR USE | AUXILIARY LABEL |
| REDUCDES A FEVER | ANTYPYRETIC DRUGS |
| PLACED IN YOUR CHEEK | BUCCAL DOSAGE FORM |
| LIQUID DOSAGE FORM IN WHICH THE SOLID PARTICLES ARE NOT COMPLETELY DISSOLVED | SUSPENSION |
| LIQUID DOSAGE FORM THAT CONSISTS OF WATER AND SUGAR MIXED WITH THE MEDICATION | SYRUP |
| LIQUID DOSAGE FORM IN WHICH THE MEDICATION IS COMPLETELY DISSOLVED IN A LIQUID | SOLUTION |
| IR FOLLOWING A DRUG NAME MEANS? | IMMEDIATE RELEASE |
| REQUIRES A PRESCRIPTION | LEGEND DRUG |
| PAPER GLUED TO THE MEDICATION BOTTLE THAT HAS DOSAGE INFORMATION, INDICATIONS, SIDE EFFECTS AND WARNINGS | PACKAGE INSERT |
| PLACED UNDER THE TONGUE | SUBLINGUAL DOSAGE FORM |
| OUTSIDE THE GI TRACT | PARENTERAL |
| AN EXPECTED EFFECT OF A MEDICATION | SIDE EFFECT |
| AN UNEXPECTED EFFECT OF A MEDICATION | ADVERSE EFFECT |
| TIME IT TAKES FOR A DRUG TO WORK AFTER THE DRUG HAS BEEN ADMINISTERED, THE RATE AT WHICH THE DRUG PASSES FROM THE INTESTINES INTO THE BLOODSTREAM | ABSORPTION |
| PROCESS FOLLOWING ABSORPTION BY WHICH A DRUG IS PASSED TO THE CELLS OF VARIOUS ORGANS | DISTRIBUTION |
| PROCESS BY WHICH THE BODY ELIMINATES WASTE AFTER METABOLISM AND DISTRIBUTION | EXCRETION |
| RELEASED AND METABOLIZED OVER A PERIOD OF TIME IN THE BODY | CONTROLLED RELEASE MEDICATIONS |
| ADMINISTRATION OF A MEDICATION BY INJECTION INTO THE SKIN | INTRADERMAL |
| ADMINSTRATION OF MEDICATION WITHIN OR INTO A MUSCLE | INTRAMUSCULAR |
| ADMINISTRATION OF A MEDICATION WITHIN OR INTO A VEIN | INTRAVENOUS |
| AMOUNT OF TIME IT TAKES FOR HALF OF A SUBSTANCE TO BE BROKEN DOWN IN THE BODY AND EXCRETED | HALF-LIFE |
| USED TO MINIMIZE THE POSSIBILITY OF SUDDEN DEATH AFTER A HEART ATTACK | BETA BLOCKER |
| USED IN THE TREATMENT OF IRREGULAR HEARTBEATS | CALCIUM-CHANNEL BLOCKER |
| USED TO BLOCK THE ENZYME THAT ACTIVATES ANGIOTENSIN | ACE INHIBITORS |
| USED TO KILL CANCER CELLS | ANTINEOPLASTIC |
| RELIEVE COUGH | ANTITUSSIVE |
| RELIEVE PAIN | ANALGESIC |
| SHRINKS MUCOUS MEMBRANES THAT PRODUCE CONGESTION | DECONGESTANT |